1997
). Production of gassericin T (GasT) was first reported in L. gasseri SBT 2055, a strain isolated 73 from adult human faeces (Kawai et al., 2000) . The amino acid sequence of GasT shows high similarity 74
to one of the peptides (LafA) of the two-component lactacin F family produced by Lactobacillus 75 johnsonii VPI11088 (Kawai et al., 2000) . Along with the LafA peptide, L. johnsonii produces another 76 hydrophobic peptide, LafX, which was highly similar to lactobin A and the predicted product of gatX 77
found in the operon of L. gasseri SBT 2055 (Kawai et al., 2000) . GatX was ultimately detected and its 78 antimicrobial activity was confirmed (Mavrič et al., 2014) and the corresponding bacteriocin has been 79 assigned to class IIb. This was considered an important finding, because in some instances where two 80
peptides are involved, one of the peptides is usually described as active and the other as the 81 complementary factor (cf) without antimicrobial activity, based on similarities with lactacin F 82 complementary component. Acidocins LF221A and LF221B were isolated from L. acidophilus LF221 83
(later renamed L. gasseri LF221), a strain isolated from infant faeces (Bogovic-Matijasic et al., 1998), 84
but the suggested assignment to the two-peptide bacteriocin group (Class IIb) has not been established 85 experimentally (Maldonado- Barragán et al., 2016) . L. gasseri K7 was also isolated from the faeces of a 86 breast-fed baby and two two-peptide bacteriocin-encoding operons were found in its genome (Zorič 87 Peternel et al., 2010) . These potential peptides shared a high homology to acidocins LF221A and 88
LF221B and gassericin T peptides, respectively (Mavrič et al., 2014) . Isolation and purification of 89 gassericin E from L. gasseri EV1461 isolated from the vagina of a healthy woman has been reported 90
(Maldonado- Barragán et al., 2016) . Gassericin E exhibits high similarity to gassericin T, differing by 91 only by one amino acid residue across the mature peptide (Maldonado- Barragán et al., 2016) . 92
Interestingly, the gassericin E operon also presents a putative bacteriocin -encoding gene, gaeX, whose 93 product shares 100% identity with GatX of L. gasseri SBT 2055 and gassericin K7 B of L. gasseri K7 94
(Maldonado-Barragán et al., 2016). Finally, genes encoding gassericin T (GatA and GatX) and the novel 95 gassericin S, with similarity to acidocin LF221A (GasA and GasX), were all found in the genome of L. 96 gasseri LA327, isolated from human large intestine tissue (Kasuga et al., 2019) . Kasuga et al 97 demonstrated the synergistic activity between the two components of gassericin T, and those of 98 gassericin S (Kasuga et al., 2019) . However, they could not demonstrate synergistic activity between 99 gassericin S and gassericin T when they mixed the four peptides together. 100
Here we report a new L. gasseri strain, LM19, isolated from human milk, which possesses three 101 bacteriocin clusters in its genome, including one encoding a novel bacteriocin, designated gassericin M. 102
Genes with homology with the paired peptides of gassericin T and gassericin S were also found in its 103 genome. All six peptides were purified and tested for antimicrobial activity. We also demonstrated that 104
LM19 survives, expresses all the bacteriocin genes and produces SCFA in detectable amounts in a 105 complex faecal environment mimicking colon conditions, and that it can help to maintain the 106 composition of the microbiome in the presence of the pathogen Clostridium perfringens. 107 108
Methods 109
Isolation and whole genome sequencing of L. gasseri LM19 110 L. gasseri LM19 was originally isolated from breast milk on MRS agar (Oxoid) at 37 o C and has been 111 deposited in the National for de novo assembly and annotation was performed using Prokka 1.11 (Seemann, 2014) .
119
Bioassay-based screening for antimicrobial activity 120
For antimicrobial overlay assays, 5 µl aliquots of L. gasseri LM19 overnight cultures were spotted onto 121 agar plates (containing 2% w/v NaHCO3 to counteract inhibition from lactic acid) and incubated for up 122 to 48 h. Bacterial spots were exposed to UV light for 15 min before being covered with 5 ml soft agar 123 (0.7%) cooled to <50 o C and inoculated with 100-200 µl of an overnight culture of an indicator strain. 124
Overlaid plates were incubated overnight at the appropriate conditions for the indicator strain. 125
Antimicrobial activity was considered positive if a zone of inhibition was seen (Balouiri et al., 2016) .
126
For cross streak assays, L. gasseri LM19 was streaked onto an agar plate containing 2% NaHCO3 and 127 incubated to allow growth. Streaks were exposed to UV light for 15 min and cross-streaked with 128 different indicator strains. For drop tests, indicator strains were cultured overnight and diluted 1:100 in 129 phosphate buffer saline (PBS). 100 µl was spread onto agar plates to produce a lawn. 10 µl of cell free 130 supernatants of L. gasseri LM19 cultures, centrifuged at 16,000 × g for 2 min and filtered through a 0.22 131 µm filter (Millipore, UK) were spotted onto the lawn. For filter disc tests, the drop test method was 132 followed but supernatants were spotted onto a 3MM Whatman filter disc that was placed onto the 133 bacterial lawn then plates were kept at 4 o C for 2 h to allow diffusion through the agar. All plates were 134 incubated overnight in appropriate conditions for the indicator strains. For well-diffusion assays, agar 135 plates were poured containing 1 ml overnight culture of the indicator strain. 50 µl of cell-free L. gasseri 136 LM19 bacterial supernatants were placed in wells made with a cork borer; plates were kept at 4 o C for 2 137 h to allow diffusion and incubated overnight. Inhibitory activity was assessed by measuring the radius 138 of inhibition (mm).
139
To assess antimicrobial activity against Campylobacter jejuni, Skirrow plates (Oxoid) were inoculated 140
with 50 μl of a C. jejuni stock in 40% glycerol and incubated overnight at 37 o C in microaerobic 141 conditions (85% N2, 5% O2, 10% CO2) in a MACS-MG-1000 controlled atmosphere cabinet (Don 142
Whitley Scientific, UK). The following day, cells grown on the plate were resuspended in 2 ml PBS and 143 a dilution of final optical density at 600 nm (OD600) = 1 was prepared in PBS. 5 ml Brucella/agar mix 144
(1.5 g agar in 100 ml of Brucella broth (Oxoid, UK) with 0.01% triphenyl tetrazolium chloride [TTC]) 145
were added to 1 ml cell aliquots and poured onto a fresh Brucella plate. Filter discs placed onto the agar 146
were spotted with 10 µl L. gasseri LM19 cell free supernatants. 10% hydrogen peroxide was used as a 147 positive control. In silico identification of bacteriocin gene clusters 160
The L. gasseri LM19 genome was analysed with software to identify putative bacteriocin clusters: 161 BAGEL 3 and BAGEL 4 (van Heel et al., 2013) to target bacteriocin clusters and antiSMASH to target 162 secondary metabolites (Weber et al., 2015) . The assembly was also annotated with RAST (Rapid 163
Annotation using Subsystem Technology) and visualised with SEED (Brettin et al., 2015) . Genome data 164
was visualised using Artemis (Carver et al., 2012) . DNA and amino acid sequences identified as putative 165
bacteriocin genes and proteins were analysed using BLAST (Altschul, 1990) to assess their relationships 166 with other peptides using default parameters. Geneious Tree Builder v11.1 (Biomatter, New Zealand) 167 was used to compare the gassericins. 168
169
Detection and purification of antimicrobial peptides 170 L. gasseri LM19 was grown anaerobically at 37 o C in 2 l MRS broth for 24-48 h. The culture was 171 centrifuged (8,000 × g, 20 min, 10 o C) to separate cells from supernatant, and both cells and supernatant 172
were analysed independently. The cell pellet was resuspended in 400 ml 70% propan-2-ol, 0.1% 173 trifluoroacetic acid (TFA -'IPA') using a stirrer for 3-4 h at room temperature, centrifuged again and 174 the supernatant retained for further purification and activity testing by drop test using L. bulgaricus 175 LMG 6901 as an indicator strain. IPA was removed from this extract by rotary evaporation until the 176 sample volume was 120 ml, and it was applied to a 2g 12 ml Strata® C18-E solid-phase extraction (C18-177 SPE) column (Phenomenex, UK), pre-equilibrated with methanol and water following manufacturer's 178
instructions. The column was washed with 20 ml of 30% ethanol and 20 ml of 30% acetonitrile and the 179 active fraction was eluted with 30 ml of IPA. The IPA was removed from the C18 SPE IPA eluate and 180 4 ml aliquots of sample applied to a semi preparative Jupiter C5 Reversed Phase HPLC column (10 x 181 250 mm, 10 μm, 300Å) (Phenomenex, Cheshire, UK) (HPLC run I) running a 30-70% acetonitrile 0.1% 182 formic acid (FA) gradient over 95 minutes where buffer A is 0.1% FA and buffer B is 100% acetonitrile 183 0.1% FA. Flow rate was 2.5 ml/min and fractions were collected at 1 min intervals. The fractions were 184 further analysed by matrix assisted laser deionisation -time of flight-mass spectrometry (MALDI-TOF-185 MS; Axima TOF 2 MALDI-TOF mass spectrometer in positive-ion reflectron mode, Shimadzu Biotech, 186 UK) to determine the masses of the potential peptides. For purification from the cell-free supernatant, 187
the supernatant was applied to an Econo-column (BioRad, UK) containing 60 g Amberlite XAD 16N. 188
The column was washed with 400 ml 35% ethanol followed by 400 ml 30% acetonitrile and 189 antimicrobial activity eluted with 450 ml IPA. The IPA was removed from the XAD IPA eluate by 190 rotary evaporation until the sample volume was 145 ml and it was then applied to a 5 g 20 ml C18-SPE 191 column pre-equilibrated with methanol and water following manufacturer's instructions. The column 192
was washed with 30 ml 30% ethanol followed by 30 ml 30% acetonitrile and antimicrobial activity 193 eluted with 30 ml IPA and fractionated by semi-preparative reversed phase HPLC as before. To increase 194 purity, some HPLC fractions were reapplied to the C5 semi prep column, running shallower gradients.
195
Specifically, 30-40% acetonitrile 0.1% FA gradient over 95 min for GamX and Bact_2, 30-45% gradient 196
for GamA, and 35-65% gradient for Bact_1, GamM and GamY. Additionally, the six peptides were 197 synthesised using microwave-assisted solid phase peptide synthesis (MW-SPPS) performed on a Liberty 198
Blue microwave peptide synthesizer (CEM Corporation, USA). GamA and GamM were synthesised on 199 a H-Lys(BOC)-HMPB)-ChemMatrix® resin, GamX was synthesised on H-Asn(Trt)-HMPB-200
ChemMatrix® resin, Bact_1 and Bact_2 on H-Arg(PBF)-HMPB-ChemMatrix® resin and GamY on 201
Fmoc-Phe-Wang (Novobiochem®, Germany) resin. Crude peptide was purified using RP-HPLC on a 202
Semi Preparative Vydac C4 (10 x 250mm, 5µ, 300Å) column (Grace, USA) running acetonitrile-0.1% 203
TFA gradients specific to the peptide of interest. Fractions containing the desired molecular mass were 204 identified using MALDI-TOF-MS on an Axima TOF2 MALDI TOF mass spectrometer and were pooled 205 and lyophilized on a Genevac HT 4X lyophilizer (Genevac Ltd., UK). All naturally produced peptides 206 and synthetic peptides, from HPLC runs, were assayed by well-diffusion assay using L. bulgaricus 207 DPC6091 to compare activity and to assess synergistic activity among them. 208 209
Transformation of L. gasseri LM19 210
Electro-competent cells of L. gasseri LM19 were made based on the method described previously (Holo 211 and Nes, 1989). Competent cells were resuspended in 2.25 ml 10% glycerol/ 0.5 M sucrose, aliquoted 212
in volumes of 40 µl and either used immediately or frozen on dry ice. 500 ng of plasmid pUK200 213 (Wegmann et al., 1999) were added to 40 µl of electro-competent cells. The mixture was incubated for 214 1 min on ice and transferred to a pre-chilled electroporation cuvette (Geneflow Limited, UK). A pulse 215 of 1500 V, 800 Ω and 25 µF was applied using a BioRad electroporator. 450 µl of pre-chilled MRS/ 20 216 mM MgCl2/ 2 mM CaCl2 were added to the cuvette and the mixture transferred to a chilled 2 ml tube 217
and incubated for 2 h at 37 o C. Aliquots were plated on MRS with 7.5 μg/ml chloramphenicol and 218 incubated overnight at 37 o C. Transformants were confirmed by colony PCR using Go Taq G2 219 polymerase (Promega) and primers p181 (5'-GCGAAGATAACAGTGACTCTA-3' and p54 (5'-220 CGGCTCTGATTAAATTCTGAAG-3') (Sigma, UK).
222
Fermentation studies 223 L. gasseri LM19 was inoculated at 1% in 20 ml of prepared in-house MRS without glucose (10 g/l 224 trypticase peptone (Difco, UK), 2.5 g/l yeast extract (Difco, UK), 3 g/l K2HPO4 (Sigma, UK), 3 g/l 225 KH2PO4 (Sigma, UK), 2 g/l tri-ammonium citrate (Sigma, UK), 0.2 g/l pyruvic acid (Sigma, UK), 0.3 226 g/l cysteine-HCl (Sigma, UK), 0.575 g/l MgSO4 . 7H2O (Sigma, UK), 0.12 g/l MnSO4 . 7H2O (Sigma, 227 UK), 0.034 g/l FeSO4 . 7H2O (Sigma, UK) and 1 ml Tween 80 (Sigma, UK)), or batch model media, 228
prepared as described previously (Parmanand et al., 2019) . The pH was adjusted to 6.8 in both media 229
and filter sterilized carbohydrate source supplementation (glucose, lactose, galactose, inulin, starch or 230 pectin [Sigma, UK]) was added at 2% after autoclaving. Fermentations were incubated in anaerobic 231
conditions at 37 o C over 48 h, conducted in triplicate and 2 ml of each sample were collected at 24 h and 232 48 h. 1 ml was used for enumeration by plate count, pH measurement using a pH-000-85282 probe 233
(Unisense, Denmark) and, once filter sterilized, antimicrobial activity using a well diffusion assay; the 234 other was centrifuged at 16,000 x g and the cell-free supernatant stored at -20 o C for further analysis.
236
In vitro colonic batch model fermentation 237
Fermentations to simulate human colon conditions were performed as described previously (Parmanand 238 et al., 2019). A faecal dilution was prepared with 10 g of fresh faecal sample diluted 1:10 in PBS, 239
homogenised using a Circulator 400 stomacher bag (Seward, UK) in a Stomacher 400 circulator 240
(Seward, UK) for two cycles of 45 s at 230 rpm and then transferred to pre-reduced batch model media 241
in a proportion 1:10, to a final volume of 150 ml, in 270 ml water-jacketed vessels (Soham Scientific, 242 UK). The temperature was maintained at 37 o C by a circulating water bath. Batch model media was 243 prepared as stated before, and 1% glucose was added as a carbohydrate source. Cultures were stirred, 244
anaerobic conditions were maintained with oxygen-free nitrogen and pH maintained between 6. FastPrep-24 homogeniser (MP Biomedicals) by applying 2 pulses of 30 s and intensity 6.0 with an 259
interval of 1 min on ice between each pulse. Samples were centrifuged for 10 min at 17,000 × g and the 260
supernatant transferred to clean 15 ml tubes and mixed with an equal volume of 70% ethanol. 70% of 261 the mixture, including any precipitate, was transferred to spin tubes and centrifuged at 8,000 × g for 1 262
min and following steps were as the manufacturer´s instructions. The RNA was eluted in 100 µl RNase-263 free water and quantified by NanoDrop 2000 (Thermo Scientific, UK). DNase treatment was performed 264 using the Turbo DNA-free TM kit (Invitrogen, UK) following the manufacturer´s protocol. cDNA 265 synthesis was carried out using the QuantiTect® Reverse Transcription Kit (Qiagen, UK) using 100 ng 266
RNA per reaction. Reverse transcription was conducted according to manufacturer's recommendations 267
and a control reaction replacing the reverse transcriptase with water was set up at the same time. The 268 presence or absence of L. gasseri LM19 bacteriocin genes was confirmed by PCR (Treven et al., 2013) . 269
Primers (Table 1) Results 318
Antimicrobial activity 319
The antimicrobial activity of L. gasseri LM19, was assessed against a variety of Gram-positive and 320
Gram-negative pathogens (Table 2) , using a number of different approaches. The assay method affected 321 the outcome, with the targets typically being more sensitive to LM19 grown on agar than to its cell free 322
supernatant. The growth of C. perfringens NCTC 3110 and L. bulgaricus 5583 was inhibited by overlay 323 assays. Cross-streaks showed antimicrobial activity against all Gram-positive indicators and C. 324 sakazakii, while supernatants exhibited activity by filter disc against L. bulgaricus, C. jejuni and M. 325
luteus. Well-diffusion assay only inhibited the growth of L. bulgaricus. As L. bulgaricus was the most 326 sensitive indicator, it was used in subsequent tests. 327 328
Identification of bacteriocin gene clusters in the genome of L. gasseri LM19 329
The sequenced genome of L. gasseri LM19 was assembled into contigs and submitted to the NCBI 330 under accession number SHO00000000. RAST analysis failed to reveal any bacteriocin clusters of 331 interest, antiSMASH 3.0 indicated the presence of a single Microcin M-like cluster, while BAGEL 4, 332
which specifically targets regions with bacteriocin similarities, found three clusters predicted to encode 333 a number of potential bacteriocins. Manual investigation confirmed the presence of two clusters, whose 334 putative structural peptides showed a high similarity to previously identified antimicrobial peptides from 335
Class IIb bacteriocins (clusters 1 and 3), and a helveticin-like protein (cluster 2). The latter contained no 336
other bacteriocin-associated genes on the basis of Blastp analysis; the product of the single gene showed 337 31.9 % identity and 43.1% amino acid consensus to helveticin J, which was originally characterised in 338
Lactobacillus helveticus following heterologous expression (Joerger and Klaenhammer, 1986 ).
339
Cluster 1 (939 bp) is highly similar to the class IIb gassericin K7A cluster (EF392861) with 99% 340 nucleotide identity. The cluster was predicted to encode two short peptides with leader sequences 341 (Bact_1 and Bact_2) and a putative immunity protein (Fig.1a ). Bact_1 homology to the gassericin T cluster from L. gasseri LA158 (AB710328, 99% over 100% coverage) 348 and the gassericin E cluster from EV1461 (KR08485, 99% over 95% coverage) ( Fig. 1a ). There are two 349 structural peptide-encoding genes, gamA and gamX, that are preceded by homologues of the gassericin 350 E cluster as described previously (Maldonado-Barragán et al., 2016). It is likely that they perform the 351 same predicted functions as their gassericin E homologues, i.e., gamP, gamK, gamR for regulation, 352
gamT and gamC for transport and, after the structural peptides, gamI for immunity, although a 353 homologue to gaeX is missing. The predicted GamA peptide has the same sequence as GasT, Gas K7B 354 cf and acidocin LF221B cf and has a single amino acid difference (W-L) from GasE (Table 3 ). The 355 second putative peptide, GamX, has the same sequence as GatX and GaeX, all of which differ by a 356 single amino acid (G-A) from Gas K7 B and acidocin LF221B (Table 3) .
357
In cluster 3, there are 7 further orfs including two additional putative structural genes, designated as 358 gamM and gamY, which appear to encode a two-component bacteriocin. These putative peptides also 359
show some similarity to other two-peptide component gassericins, but to a lesser extent than those 360 previously reported (Fig. 1b) Surrounding gamY and gamM are two genes encoding putative immunity proteins, GamI2 and GamI3, 364
with homology to an enterocin A immunity domain (pfam 08951, 2.8e -7 and 1.1e -6 , respectively), a 365 putative transport accessory protein, GamC2, with some similarity to TIGR01295 bacteriocin transport 366 accessory protein (1.18e -9 ), and thioredoxin superfamily cd02947 (5.21e -7 ), and two orfs with no 367 matches. The genes on either side of the cluster show amino acid homology to transporters involved in 368 solute or cation transport, and so are not predicted to be part of the cluster. 369 370
Identification of antimicrobial peptides in culture 371
Cell and supernatant extracts from L. gasseri LM19 cultures were fractionated by HPLC and analysed 372 by MS and their antimicrobial activity was assessed using L. bulgaricus 6901 as an indicator (Fig. 2 and  373 3). Antimicrobial activity was present in both cells and supernatant ( Fig. 2a ). MS shows that all peptide 374 masses of interest are present. 375 376
Purification of bacteriocins from cells 377 MS analysis of HPLC fractions showed that many fractions contained one or more peptide masses that 378
were consistent with those predicted by in silico analysis of the genome (Table 3 , Fig. 2 and 3 ). mV 379 response was very low (40 mV compared to around 1000 mV from a good producer), suggesting that 380 production and consequently yield was very low. A mass corresponding to GamX (4763 Da) was 381 detected in fractions 32-36 ( Fig. 3a) . Fractions 37-39 showed a mass corresponding to GamA, 5541 Da 382 (Fig. 3b) . Masses corresponding to GamY and GamM co-eluted in fraction 49-55 ( Fig. 3c ). Fractions 383 57-60 showed the expected mass from Bact_1, 6060 Da (Fig. 3d ). Fractions 85-97 showed putative 384
GamM mass, 4126 Da (Fig. 3e ).
386
Purification of bacteriocins from supernatants 387 MS analysis of the HPLC fractions 20-97 from the first HPLC run showed masses corresponding to 388
Bact_1 and GamM (Fig. S1) . Masses corresponding to putative Bact_1 eluted in fractions 59-65, while 389
putative GamM mass was detected in fractions 76-97. Masses corresponding to Bact_2 and GamA 390 eluted also in the first HPLC fractionation and were fractionated again. GamX eluted in fractions 86-90 391 (Fig. 3e) , and also in fractions 66-68, co-eluting with GamA. Putative Bact_1 eluted in fractions 58-60. 392
GamY eluted in fractions 69-72, and GamM showed in fractions 86-91 ( Fig. S2 and S3 ).
394
Synergy between peptides 395
Three sets of fractions were compared, fractions from HPLC run I, fractions from HPLC II run and 396 synthetic peptides resuspended in milli Q water at 1 mg/ml (Fig. 4a ). All synthetic peptides, except 397
GamY, showed antimicrobial activity, with the highest activity coming from GamA and Bact_2. Fig. 4b  398 and c show synergy assays between synthetic peptides. We observed clear synergy between Bact_1 and 399
Bact_2 and a possible synergy between Bact_1 and GamA. No synergy was observed between GamM 400
and GamY or between GamA and GamX. 401 402
Complex carbohydrates can favor viability and antimicrobial activity of L. gasseri LM19 403 L. gasseri LM19 was grown in colon model medium, simulating gut conditions, or home-made MRS, 404 alone or supplemented with simple sugars (glucose, lactose and galactose) or complex polymers (inulin, 405 starch and pectin). In general, more viable cells were recovered from MRS; growth on simple sugars 406 was highest at 24 h but, at 48 h, complex carbohydrates gave higher counts (Fig. 5a ). Interestingly, 407
growth in the absence of a carbon source at 48 h was similar to that with simple sugars. On batch model 408 medium, cell counts with glucose were lower than with all other treatments, and starch and pectin 409 improved growth at 48 h. Antimicrobial activity from batch model medium with glucose was almost as 410 high as that from MRS despite a ~3 log difference in cfu (Fig. 5b ). Glucose and galactose 411 supplementation showed the highest antimicrobial activity at 24 h while, complex carbohydrates 412 produced the highest activity after 48 h. At 48 h, higher levels of antimicrobial activity correlated with 413
lower pH values and higher levels of cfu. 414
The changes in activity with carbon supplementation over time suggest control of antimicrobial 415 production in different nutritional environments. Examination of bacteriocin gene expression in MRS 416
also showed that no carbon supplementation increased the expression of gamM and gam Y significantly 417 at 48 h. Starch supplementation increased the expression of both genes at 24 h, as did inulin at 48 h. 418
Galactose supplementation also produced a significant increase in expression of gamM at 48 h and gamY 419 at 24 and 48 h (Fig. 5c ). Other bacteriocin genes did not show notable changes in expression, except for 420
an increase in expression of the helveticin J-like gene in the presence of starch at 24 h (supplementary 421  Table S1 ).
423
In vitro colon model fermentations with L. gasseri LM19 424
Survival of L. gasseri LM19 and C. perfringens in an in vitro colon model 425 L. gasseri LM19 was transformed with a plasmid conferring chloramphenicol resistance to allow 426 selection and enumeration of this strain within a mixed microbial community. Transformation of 427 electrocompetent cells gave an efficiency of 1.07x10 2 transformants/ng of DNA. Fermentations with 428 three different faecal donors were performed with four vessels per fermentation inoculated with L. 429 gasseri LM19-pUK200, C. perfringens NCTC 3110, L. gasseri with C. perfringens, or a media control.
430
L. gasseri numbers recovered increased from 5.3, 5.22 and 5.22 log10 cfu/ml in donors 1, 2 and 3, 431
respectively at 4 h, to 6.12, 6.39 and 6.36 log10 cfu/ml at 8 h and 7.30, 7.31 and 7.47 log10 cfu/ml at 24 432 h. However, after 48 h, levels of recovery dropped to 3.66, 4 and 3.72 log10 cfu/ml.
433
C. perfringens levels were measured by qPCR, which detects DNA from both live and dead cells. 434
Addition of L. gasseri LM19 did not have a negative effect on the C. perfringens population in the 435 fermentation with faecal sample from donor 1; there was a tendency to lower C. perfringens counts in 436
co-culture at 24 h with donors 2 and 3, but the changes were not significant (Fig. 6a ).
438
Bacteriocin gene expression 439 PCR amplification of cDNA obtained from colon model samples using primers to detect the bacteriocin 440 genes bact_1, bact_2, helveticin-J like, gamA, gamX, gamM and gamY, showed detectable levels of 441 bacteriocin gene expression at 24 h ( Fig. 6b) . At 48 h, expression of only helveticin-J like, gamM and 442
gamY genes was detected (data not shown).
444
Impact of L. gasseri LM19 on gut microbiota composition 445
Analysis of relative abundance at order, family and genus level was conducted. The initial bacterial 446 composition was, as expected, different between the three donors ( Fig. 6c ). Bacterial populations from 447 donor 1 remained relatively stable over 24 h. The addition of L. gasseri LM19, C. perfringens or both 448 did not result in a significant increase in proportions of Lactobacillales or Clostridiales, and all 3 449 treatments resulted in similar increases in Bifidobacteriales and Coriobacteriales relative to the control, 450
with the L. gasseri LM19 with C. perfringens treatment more similar to the L. gasseri LM19 only 451
condition. 452
The initial population from donor 2 was constituted mainly of Clostridiales, with some Bacteroidales, 453
Coriobacteriales and Bifidobacteriales. A change can be observed at 24 h in both the control and the 454 samples where L. gasseri LM19 or L. gasseri LM19 with C. perfringens were added, with an increase 455
in Lactobacillales along with a small increase in Enterobacteriales. The decrease in relative abundance 456 of Bifidobacteriales and Coriobacteriales in the control, L. gasseri and C. perfringens + L. gasseri 457 treatments was statistically significant (p<0.05) and not observed in the C. perfringens sample. C. 458
perfringens alone appeared to prevent the overgrowth of Lactobacillales, while Clostridiales were 459 decreased, being replaced by Enterobacteriales, Bacteroidales, Coriobacteriales and Bifidobacteriales. 460
It was noted that addition of L. gasseri LM19 with C. perfringens gave a profile with more similarity to 461 the control or L. gasseri LM19 samples. 462
In L. gasseri LM19 treatment of donor 3 samples, Bifidobacteriales and Enterobacteriales increased 463 over time in a similar way to the control, but Clostridiales were almost completely replaced by 464
Lactobacillales. This rise was not as large when the L. gasseri LM19 was co-inoculated with C. 465
perfringens, while addition of C. perfringens alone did not manage to maintain levels of Clostridales, 466
with increases seen in Enterobacteriales, Bifidobacteriales and Lactobacillales. In this case, the L. 467
gasseri LM19 + C. perfringens treatment at 24 h was more similar to the control, with the exception of 468 the presence of Lactobacillales, suggesting that the C. perfringens effect on the microbial composition 469
was changed by the inoculation with L. gasseri. 470 471 SCFA analysis 472
Increases in the production of formic, acetic, propionic and butyric acids were observed in the three 473
faecal fermentations in colon model conditions inoculated with L. gasseri LM9. However, there was a 474
high variability in SCFA production between the three donors ( Fig. 6d ). In donor 1, production of SCFA, 475
ethanol, succinate and, at 8 h only, lactate was increased compared to the control. In donor 2 there were 476 notable increases in lactic acid from 4 h. Given the similar relative abundance of Lactobacillales (Fig.  477 6d) in control and L. gasseri treatment, this suggests an influence of L. gasseri LM19 on the native 478 microbiota. 479 480
Discussion 481
Here we report the ability of a representative of the human breast milk microbiota to exhibit antagonistic 482 activity against different enteropathogens via production of previously identified bacteriocins and one 483 novel bacteriocin. We have observed different carbon sources have an influence on the expression of 484 these bacteriocin genes. L. gasseri LM19 survived and expressed these antimicrobial genes in a complex 485
faecal environment under simulated colon conditions. This can be considered an important feature, since 486 not all strains that exhibit probiotic traits are able to survive in colon conditions and, therefore, deliver 487 their activity in situ. Additionally, we have observed other characteristics that are considered useful, 488
such as the production of SCFA.
489
The presence of bacteria in human breast milk has been reported previously and the existence of a 490 bacterial entero-mammary pathway has recently been proposed (Rodríguez, 2014) . These bacteria might 491 have a gut origin and that could explain their ability to survive in GI tract conditions and exhibit 492 antagonistic traits against other gut bacteria such as enteropathogens that might share the same 493 environment. Gassericins are antimicrobial peptides produced by L. gasseri. Several gassericins have 494 been identified in sets of four, comprising two-peptide class II bacteriocins. K7 bacteriocins are a variant 495 of acidocins LF221 and share similar sequences to GasT and its complementary peptide GatX, 496
respectively, while GasE could be considered a variant of GasT. These two-peptide bacteriocins also 497
show similarities with other two-peptide bacteriocins isolated from species previously grouped with L. 498
gasseri (Tahara et al., 1996) . L. gasseri LM19 also presents two clusters of bacteriocins that show 499 homology to acidocin LF221A and Gas K7A on one hand and acidocin LF221B and Gas K7B on the 500 other hand. Additionally, we observed the presence of structural genes corresponding to a new two-501 component bacteriocin that show a greater variation in sequence to previously described gassericins. 502
Partial purification of the products of these structural genes was conducted and we observed the presence 503 of masses matching the expected size in eluted fractions that exhibited antimicrobial activity. 504
Particularly, masses predicted to match those of the new potential peptides GamM (4124 Da) and GamY 505 (4105 Da) were associated with antimicrobial activity. Synthetic peptides confirmed the activity of 506
GamM but GamY did not show activity or synergy with GamM. Synergistic activity was reported 507
previously between GasT and GatX and between the two components of gassericin S (here Bact_1 and 508
Bact_2), respectively (Kasuga et al., 2019) . While Bact_1 and Bact_2 showed synergistic activity, the 509
GasT and GatX homologues from this study, GamA and GamX, did not. However, we could observe a 510 possible synergistic activity between GamA and Bact_1.
511
We demonstrated that L. gasseri LM19 is able to survive in simulated colon conditions within a complex 512 faecal microbiota. Moreover, it is capable of expressing the bacteriocin genes in this environment. In 513 previous work it was demonstrated that another potentially probiotic L. gasseri, strain K7, which 514 produced 2 two-peptide bacteriocins K7 A, K7 A (cf), K7 B and K7 B (cf), was able to survive in faecal 515
samples. Its bacteriocins were also the focus of examination by conventional PCR and RT-PCR (Treven 516 et al., 2013) . In that instance the authors noted that bacteriocin genes were amplified by PCR from other 517 LAB species present in the environment. However, in our controls and treatments where L. gasseri 518
LM19 was not present, no PCR products were detected. 519 L. gasseri LM19 showed mixed effects on a strain of C. perfringens added to faecal fermentations of 520 three different donors, causing a slight decrease in C. perfringens in only 2 out of 3 fermentations. This 521 might indicate that the surrounding microbiota plays a synergistic or antagonistic role on the effect of 522 L. gasseri LM19. However, it should be noted that in antimicrobial assays C. perfringens was only 523
inhibited by L. gasseri LM19 cells, not cell-free supernatant, which might suggest that they should be 524
in close proximity for an antimicrobial effect. However, co-inoculation of L. gasseri LM19 with C. 525
perfringens did seem to alter the effect of C. perfringens on the background microbiota. In all three 526 donors, the profiles seen after addition of L. gasseri LM19 with C. perfringens were more similar to 527 instances where L. gasseri was added alone or control samples than to samples containing only C. 528
perfringens. 529
Colon model fermentations also allowed the production of formic, acetic, propionic and butyric acids to 530 be quantified using NMR. We observed an increase in SCFA production in the faecal fermentation of 531 the three donors. However, as with the microbial composition, the amount of each SCFA produced was 532 very different from one donor to another, which might be related to production by other members of the 533 microbiota that varied between the three donors. In a previous study of consumption of a beverage 534 prepared with L. gasseri CP2305, the stools of the participants presented an increased level of SCFA 535 too, while the microbiota experienced some alterations, including an increase in the presence of bacteria 536
from Clostridium cluster IV, known for producing higher amounts of SCFA (Sawada et al., 2016) . The 537
authors of that study could not conclude if the increase of SCFA was due to the effect of L. gasseri or 538
due to the proliferation of bacteria that produced more SCFA. SCFA production also depends on diet 539
and availability of nutrients in the gastrointestinal tract as well as the resident microbiota (den Besten et 540 al., 2013; Holmes et al., 2017) . 541
This work shows the ability of L. gasseri LM19, a multi-bacteriocin breast milk isolate, to survive in 542 colon conditions. Its ability to express different bacteriocin genes, including a novel gassericin M, under 543 these conditions, makes it a candidate for further application studies. 544 545
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